US Patent Litigations are now available. Check here

IP Verse

Patent opposition analysis in Infection Drugs industry

In the competitive field of Infection Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Infection Drugs technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Infection Drugs Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Jun 12, 2025
CompanyTotal Oppositions
SANDOZ8
STRAWMAN8
GENERICS UK7
TEVA PHARMACEUTICAL INDUSTRIES7
NUTRICIA7
COOKE6
FRESENIUS KABI DEUTSCHLAND5
FRIESLANDCAMPINA NEDERLAND4
HGF4
PFIZER4

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jun 12, 2025
CompanyTotal Oppositions
VIIV HEALTHCARE17
GILEAD SCIENCES11
NUTRICIA10
GLAXOSMITHKLINE BIOLOGICALS8
MERCK SHARP & DOHME8
NESTEC7
SOCIT DES PRODUITS NESTL7
INTERVET6
NOVARTIS5
ESTEVE QUMICA5

Top active law firms filing patent oppositions

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Last updated on: Jun 12, 2025
CompanyTotal Oppositions Filed
D YOUNG16
ELKINGTON AND FIFE15
TER MEER STEINMEISTER & PARTNER13
HOFFMANN EITLE8
CARPMAELS & RANSFORD8
NEDERLANDSCH OCTROOIBUREAU7
MEWBURN ELLIS6
HAMM&WITTKOPP PATENTANWALTE PARTMBB6
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB6
FRESENIUS KABI DEUTSCHLAND5

Latest patents opposed in the Infection Drugs industry

Patent challenges are becoming increasingly common in the Infection Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Infection Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jun 12, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Infection Drugs industry

EP3781210Treatment Of Sepsis And Septic ShockCOMBIOXINMay 6, 2025BRAND MURRAY FULLER
EP3677246Antibacterial Antifungal CompositionADEKAApr 15, 2025BEIERSDORF
EP3932410Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025BRULIE
EP3932410Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
EP4216715Moisturizing Antibacterial CompositionUNILEVERMar 13, 2025HENKEL
EP4181933Antiviral Pharmaceutical Composition Comprising At Least One Sulphate PolysaccharideMARINOMED BIOTECHJan 17, 2025HAMPTON KNOWLES
EP3565551Methods Of Treating Bacterial InfectionsMELINTA THERAPEUTICSDec 20, 2024GENERICS UK
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 13, 2024ELKINGTON AND FIFE
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 12, 2024SANDOZ
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 11, 2024HAMM&WITTKOPP PATENTANWALTE PARTMBB

Top patents facing oppositions in Infection Drugs industry

To stay ahead in the competitive Infection Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Infection Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3494972Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
EP3597216Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONS5
EP2899193Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUMICA5
EP3127542Aug 22, 2018Antiviral TherapyVIIV HEALTHCARE4
EP3391890Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-CyclodextrinMERCK SHARP & DOHME4
EP4008357Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS4
EP3153526Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE4
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES3
EP3150586Jan 8, 2020Modulators Of Pharmacokinetic Properties Of TherapeuticsGILEAD SCIENCES3
EP2397155Dec 13, 2017Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayDANA FARBER CANCER INSTITUTE3